ClearNote Health Raises $52 Million for Early Cancer Detection Tests
The funding will support commercial expansion of the company’s blood-based diagnostic tests and the appointment of a new president and chief operating officer.
Latest Articles
Editor's Top Picks
How Labs Are Driving the Andes Hantavirus Outbreak Response
Laboratories are leveraging established diagnostic and surveillance tools to track the Andes hantavirus outbreak linked to a cruise ship, with experts noting no evidence of widespread community transmission or efficient airborne spread.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
At-Home Finger Prick Blood Test May Screen for Dementia Risk
New research suggests that remote capillary sampling for Alzheimer’s biomarkers correlates with cognitive test performance in older adults.
Equipment & Supply Spotlight
Cenevo Adds Natural Language Search to Mosaic Lab Inventory Platform
Cenevo has introduced an AI-powered natural language search feature to its Mosaic lab inventory platform, enabling scientists to locate samples using plain language queries while maintaining data traceability.
News, Know-How & Standards
Disease Detection & Understanding
FDA Grants Breakthrough Designation to AI Bladder Cancer Prognostic Test
The FDA has granted Breakthrough Device Designation to Valar Labs’ Vesta Bladder Risk Stratify Dx, the first AI-powered digital pathology prognostic test for bladder cancer.
